-
1Academic Journal
المؤلفون: Olaru-Stăvilă, C., Tcaciuc, E.M., Ткачук, Е.М., Ardeleanu, D.
المصدر: Sănătate Publică, Economie şi Management în Medicină 97_S (4) 40-47
مصطلحات موضوعية: peritonită bacteriană spontană, ciroza hepatică, paracenteză, pontaneous bacterial peritonitis, liver cirrhosis, paracentesis, спонтанный бактериальный перитонит, цирроз печени, парацентез
وصف الملف: application/pdf
Relation: https://ibn.idsi.md/vizualizare_articol/194417; urn:issn:17298687
-
2Academic Journal
المؤلفون: G. A. Ignatenko, T. E. Kugler, G. G. Taradin, I. V. Rakitskaya, A. A. Kaluga, Г. А. Игнатенко, Т. Е. Куглер, Г. Г. Тарадин, И. В. Ракитская, А. А. Калуга
المساهمون: The study was performed without external funding. The authors express their gratitude to Elena N. Polyanchikova for her assistance with graphic material, Работа выполнена без спонсорской поддержки. Авторы выражают благодарность Е.Н. Полянчиковой за оказанную помощь в работе с графическим материалом
المصدر: Safety and Risk of Pharmacotherapy; Том 10, № 2 (2022); 161-175 ; Безопасность и риск фармакотерапии; Том 10, № 2 (2022); 161-175 ; 2619-1164 ; 2312-7821
مصطلحات موضوعية: ALFA-помпа, ascites, diuretics, paracentesis, liver transplantation, adverse reactions, transjugular intrahepatic portosystemic shunt, Alfapump, асцит, диуретики, нежелательные реакции, парацентез, трансплантация печени, трансъюгулярное внутрипеченочное портосистемное шунтирование
وصف الملف: application/pdf
Relation: https://www.risksafety.ru/jour/article/view/273/550; https://www.risksafety.ru/jour/article/downloadSuppFile/273/244; https://www.risksafety.ru/jour/article/downloadSuppFile/273/246; Ивашкин ВТ, Маевская МВ, Павлов ЧС, Федосьина ЕА, Бессонова ЕН, Пирогова ИЮ, Гарбузенко ДВ. Клинические рекомендации Российского общества по изучению печени и Российской гастроэнтерологической ассоциации по лечению осложнений цирроза печени. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2016;26(4):71–102.; European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53(3):397–417. https://doi.org/10.1016/j.jhep.2010.05.004; Дядык АИ, Куглер ТЕ, Маловичко ИС, Яровая НФ, Ракитская ИВ. Принципы диуретической терапии при лечении больных циррозом печени. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2017;27(5):48–56.; Gordon FD. Ascites. Clin Liver Dis. 2012;16(2):285–99. https://doi.org/10.1016/j.cld.2012.03.004; Zhao R, Lu J, Shi Y, Zhao H, Xu K, Sheng J. Current management of refractory ascites in patients with cirrhosis. J Int Med Res. 2018;46(3):1138–45. https://doi.org/10.1177/0300060517735231; Pedersen JS, Bendtsen F, Møller S. Management of cirrhotic ascites. Ther Adv Chronic Dis. 2015;6(3):124– 37. https://doi.org/10.1177/2040622315580069; Reynolds TB. Ascites. Clin Liver Dis. 2000;4(1):151– 68. https://doi.org/10.1016/s1089-3261(05)70101-x; Hasan M, Akbar SMF, Al Mahtab M, Kumar PJ. Textbook of hepato-gastroenterology. 1st edition. New Delhi: Jaypee Brothers Medical Publishers; 2015.; Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2003;38(1):258–66. https://doi.org/10.1053/jhep.2003.50315; Garbuzenko DV, Arefyev NO. Current approaches to the management of patients with cirrhotic ascites. World J Gastroenterol. 2019;25(28):3738–52. https://doi.org/10.3748/wjg.v25.i28.3738; Arroyo V, Fernandez J. Relationship between systemic hemodynamics, renal dysfunction, and fluid retention in cirrhosis. Clin Liver Dis (Hoboken). 2013;2(3):120–2.; Solà E, Ginès P. Renal and circulatory dysfunction in cirrhosis: current management and future perspectives. J Hepatol. 2010;53(6):1135–45.; Bernardi M, Domenicali M. The renin-angiotensin-aldosterone system in cirrhosis. In: Ginès P, Arroyo V, Rodés J, Schrier RW, eds. Ascites and renal dysfunction in liver disease: pathogenesis, diagnosis and treatment. Malden: Blackwell; 2005. P. 43–54.; Ginès P, Cárdenas A, Schrier RW. Liver disease and the kidney. In: Schrier RW, ed. Diseases of the kidney and urinary tract. Philadelphia: Lippincott Williams & Wilkins; 2007. P. 2179–2205.; Arroyo V, Terra C, Ginès P. Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome. J Hepatol. 2007;46(5):935–46. https://doi.org/10.1016/j.jhep.2007.02.001; Bernardi M, Moreau R, Angeli P, Schnabl B, Arroyo V. Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis. J Hepatol. 2015;63(5):1272–84. https://doi.org/10.1016/j.jhep.2015.07.004; Neong SF, Adebayo D, Wong F. An update on the pathogenesis and clinical management of cirrhosis with refractory ascites. Expert Rev Gastroenterol Hepatol. 2019;13(4):293–305. https://doi.org/10.1080/17474124.2018.1555469; Dirchwolf M, Podhorzer A, Marino M, Shulman C, Cartier M, Zunino M, et al. Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity. Cytokine. 2016;77:14–25. https://doi.org/10.1016/j.cyto.2015.10.006; Mandorfer M, Schwabl P, Paternostro R, Pomej K, Bauer D, Thaler J, et al. Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity. Aliment Pharmacol Ther. 2018;47(7):980–8. https://doi.org/10.1111/apt.14522; Rimola A, García-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, Inadomi JM. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol. 2000;32(1):142–53. https://doi.org/10.1016/s0168-8278(00)80201-9; Adebayo D, Neong SF, Wong F. Refractory ascites in liver cirrhosis. Am J Gastroenterol. 2019;114(1):40–7. https://doi.org/10.1038/s41395-018-0185-6; Wong F, Bendel E, Sniderman K, Frederick T, Haskal ZJ, Sanyal A, et al. Improvement in quality of life and decrease in large-volume paracentesis requirements with the automated low-flow ascites pump. Liver Transpl. 2020;26(5):651–61. https://doi.org/10.1002/lt.25724; Piano S, Tonon M, Angeli P. Management of ascites and hepatorenal syndrome. Hepatol Int. 2018;12(Suppl 1):122–34. https://doi.org/10.1007/s12072-017-9815-0; Biecker E. Diagnosis and therapy of ascites in liver cirrhosis. World J Gastroenterol. 2011;17(10):1237–48. https://doi.org/10.3748/wjg.v17.i10.1237; Aithal GP, Palaniyappan N, China L, Harmala S, Macken L, Ryan JM, et al. Guidelines on the management of ascites in cirrhosis. Gut. 2021;70(1):9–29. https://doi.org/10.1136/gutjnl-2020-321790; Tzamaloukas AH, Malhotra D, Rosen BH, Raj DSC, Murata GH, Shapiro JI. Principles of management of severe hyponatremia. J Am Heart Assoc. 2013;2(1):e005199. https://doi.org/10.1161/jaha.112.005199; Дядык АИ, Тарадин ГГ, Сулиман ЮВ, Зборовский СР, Меркурьев ВИ. Диуретики при хронической болезни почек. Архивъ внутренней медицины. 2020;10(1):10–20. https://doi.org/10.20514/2226-6704-2020-10-1-10-20; Kasztelan-Szczerbinska B, Cichoz-Lach H. Refractory ascites — the contemporary view on pathogenesis and therapy. Peer J. 2019;7:e7855. https://doi.org/10.7717/peerj.7855; Guo TT, Yang Y, Song Y, Ren Y, Liu ZX, Cheng G. Effects of midodrine in patients with ascites due to cirrhosis: Systematic review and meta-analysis. J Dig Dis. 2016; 17(1):11–9. https://doi.org/10.1111/1751-2980.12304; Hanafy AS, Hassaneen AM. Rifaximin and midodrine improve clinical outcome in refractory ascites including renal function, weight loss, and short-term survival. Eur J Gastroenterol Hepatol. 2016;28(12):1455– 61. https://doi.org/10.1097/meg.0000000000000743; Lenaerts A, Codden T, Meunier JC, Henry JP, Ligny G. Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system. Hepatology. 2006;44(4):844–9. https://doi.org/10.1002/hep.21355; Yang YY, Lin HC, Lee WP, Chu CJ, Lin MW, Lee FY, et al. Association of the G-protein and α2-adrenergic receptor gene and plasma norepinephrine level with clonidine improvement of the effects of diuretics in patients with cirrhosis with refractory ascites: a randomised clinical trial. Gut. 2010;59(11):1545–53. https://doi.org/10.1136/gut.2010.210732; EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406–60. https://doi.org/10.1016/j.jhep.2018.03.024; Zhou X, Tripathi D, Song T, Shao L, Han B, Zhu J, et al. Terlipressin for the treatment of acute variceal bleeding: a systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2018;97(48):e13437. https://doi.org/10.1097/md.0000000000013437; Colle I, Laterre PF. Hepatorenal syndrome: the clinical impact of vasoactive therapy. Expert Rev Gastroenterol Hepatol. 2018;12(2):173–88. https://doi.org/10.1080/17474124.2018.1417034; Møller S, Hansen EF, Becker U, Brinch K, Henriksen JH, Bendtsen F. Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients. Liver. 2000;20(1):51–9. https://doi.org/10.1034/j.1600-0676.2000.020001051.x; Krag A, Møller S, Henriksen JH, Holstein-Rathlou NH, Larsen FS, Bendtsen F. Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome. Hepatology. 2007;46(6):1863– 71. https://doi.org/10.1002/hep.21901; Kalambokis G, Economou M, Fotopoulos A, Bokharhii JA, Katsaraki A, Tsianos EV. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites. Nephrol Dial Transplant. 2005;20(8):1623–9. https://doi.org/10.1093/ndt/gfh871; Zhang X, Wang SZ, Zheng JF, Zhao WM, Li P, Fan CL, et al. Clinical efficacy of tolvaptan for treatment of refractory ascites in liver cirrhosis patients. World J Gastroenterol. 2014;20(32):11400–5. https://doi.org/10.3748/wjg.v20.i32.11400; Bellos I, Kontzoglou K, Psyrri A, Pergialiotis V. Tolvaptan response improves overall survival in patients with refractory ascites: a meta-analysis. Dig Dis. 2020;38(4):320–8. https://doi.org/10.1159/000503559; Rodrigues SG, Mendoza YP, Bosch J. Beta-blockers in cirrhosis: evidence-based indications and limitations. JHEP Rep. 2019;2(1):100063. https://doi.org/10.1016/j.jhepr.2019.12.001; Krag A, Wiest R, Albillos A, Gluud LL. The window hypothesis: haemodynamic and non-haemodynamic effects of β-blockers improve survival of patients with cirrhosis during a window in the disease. Gut. 2012;61(7):967–9. https://doi.org/10.1136/gutjnl-2011-301348; Brito-Azevedo A. Diuretic window hypothesis in cirrhosis: Changing the point of view. World J Gastroenterol. 2019;25(26):3283–90. https://doi.org/10.3748/wjg.v25.i26.3283; Chirapongsathorn S, Valentin N, Alahdab F, Krittanawong C, Erwin PJ, Murad MH, Kamath PS. Nonselective β-blockers and survival in patients with cirrhosis and ascites: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016;14(8):1096–104.e9. https://doi.org/10.1016/j.cgh.2016.01.012; De Gottardi A, Thévenot T, Spahr L, Morard I, Bresson-Hadni S, Torres F, et al. Risk of complications after abdominal paracentesis in cirrhotic patients: a prospective study. Clin Gastroenterol Hepatol. 2009;7(8):906–9. https://doi.org/10.1016/j.cgh.2009.05.004; Montalto P, Vlachogiannakos J, Cox DJ, Pastacaldi S, Patch D, Burroughs AK. Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study. J Hepatol. 2002;37(4):463–70. https://doi.org/10.1016/s0168-8278(02)00208-8; Hung A, Garcia-Tsao G. Acute kidney injury, but not sepsis, is associated with higher procedure-related bleeding in patients with decompensated cirrhosis. Liver Int. 2018;38(8):1437–41. https://doi.org/10.1111/liv.13712; Kim JH. What we know about paracentesis induced circulatory dysfunction? Clin Mol Hepatol. 2015;21(4):349– 51. https://doi.org/10.3350/cmh.2015.21.4.349; Bernardi M, Caraceni P, Navickis RJ, Wilkes MM. Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials. Hepatology. 2012;55(4):1172–81. https://doi.org/10.1002/hep.24786; Bernardi M, Caraceni P, Navickis RJ. Does the evidence support a survival benefit of albumin infusion in patients with cirrhosis undergoing large-volume paracentesis? Expert Rev Gastroenterol Hepatol. 2017;11(3):191–2. https://doi.org/10.1080/17474124.2017.1275961; Di Pascoli M, Fasolato S, Piano S, Bolognesi M, Angeli P. Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites. Liver Int. 2019;39(1):98–105. https://doi.org/10.1111/liv.13968; Kozaki K, IInuma M, Takagi T, Fukuda T, Sanpei T, Terunuma Y, et al. Cell-free and concentrated as cites reinfusion therapy for decompensated liver cirrhosis. Ther Apher Dial. 2016;20(4):376–82. https://doi.org/10.1111/1744-9987.12469; Bai M, Qi XS, Yang ZP, Yang M, Fan DM, Han GH. TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis. World J Gastroenterol. 2014;20(10):2704–14. https://doi.org/10.3748/wjg.v20.i10.2704; Allegretti AS, Ortiz G, Cui J, Wenger J, Bhan I, Chung RT, et al. Changes in kidney function after transjugular intrahepatic portosystemic shunts versus large-volume paracentesis in cirrhosis: a matched cohort analysis. Am J Kidney Dis. 2016;68(3):381–91. https://doi.org/10.1053/j.ajkd.2016.02.041; Bercu ZL, Fischman AM, Kim E, Nowakowski FS, Patel RS, Schiano TD, et al. TIPS for refractory ascites: a 6-year single-center experience with expanded polytetrafluoroethylene-covered stentgrafts. AJR Am J Roentgenol. 2015;204(3):654–61. https://doi.org/10.2214/ajr.14.12885; Bureau C, Thabut D, Oberti F, Dharancy S, Carbonell N, Bouvier A, et al. Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites. Gastroenterology. 2017;152(1):157– 63. https://doi.org/10.1053/j.gastro.2016.09.016; Miraglia R, Maruzzelli L, Tuzzolino F, Petridis I, D’Amico M, Luca A. Transjugular intrahepatic portosystemic shunts in patients with cirrhosis with refractory ascites: comparison of clinical outcomes by using 8- and 10-mm PTFEcovered stents. Radiology. 2017;284(1):281–8. https://doi.org/10.1148/radiol.2017161644; Rudler M, Mallet M, Sultanik P, Bouzbib C, Thabut D. Optimal management of ascites. Liver Int. 2020; 40(Suppl 1):128–35. https://doi.org/10.1111/liv.14361; Sarwar A, Zhou L, Novack V, Tapper EB, Curry M, Malik R, Ahmed M. Hospital volume and mortality after transjugular intrahepatic portosystemic shunt creation in the United States. Hepatology. 2018;67(2):690–9. https://doi.org/10.1002/hep.29354; Bellot P, Welker MW, Soriano G, von Schaewen M, Appenrodt B, Wiest R, et al. Automated low flow pump system for the treatment of refractory ascites: a multi-center safety and efficacy study. J Hepatol. 2013;58(5):922–7. https://doi.org/10.1016/j.jhep.2012.12.020; Stirnimann G, Berg T, Spahr L, Zeuzem S, McPherson S, Lammert F, et al. Treatment of refractory ascites with an automated low-flow ascites pump in patients with cirrhosis. Aliment Pharmacol Ther. 2017;46(10):981–91. https://doi.org/10.1111/apt.14331; Bureau C, Adebayo D, Chalret de Rieu M, Elkrief L, Valla D, Peck-Radosavljevic M, et al. Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study. J Hepatol. 2017;67(5):940–9. https://doi.org/10.1016/j.jhep.2017.06.010; Lepida A, Marot A, Trépo E, Degre D, Moreno C, Deltenre P. Systematic review with meta-analysis: automated low-flow ascites pump therapy for refractory ascites. Aliment Pharmacol Ther. 2019;50(9):978–87. https://doi.org/10.1111/apt.15502; Wong F, Bendel E, Sniderman K, Frederick T, Haskal ZJ, Sanyal A, et al. Improvement in quality of life and de crease in large-volume paracentesis requirements with the automated low-flow ascites pump. Liver Transpl. 2020;26(5):651–61. https://doi.org/10.1002/lt.25724; Senousy BE, Draganov PV. Evaluation and management of patients with refractory ascites. World J Gastroenterol. 2009;15(1):67–80. https://doi.org/10.3748/wjg.15.67; https://www.risksafety.ru/jour/article/view/273
-
3Academic Journal
المؤلفون: S. Morozova V., K. Eremeeva V., W. Suaifan H.A., E. Pawlushina M., С. Морозова В., К. Еремеева В., В. Суайфан Х.А., Е. Павлюшина М.
المصدر: Meditsinskiy sovet = Medical Council; № 18 (2021); 212-216 ; Медицинский Совет; № 18 (2021); 212-216 ; 2658-5790 ; 2079-701X
مصطلحات موضوعية: external auditory canal, microbiota, ear wax, endaural approach, preoperative preparation, paracentesis, stapedoplasty, наружный слуховой проход, микробиота, сера, эндауральный доступ, предоперационная обработка, парацентез, стапедопластика
وصف الملف: application/pdf
Relation: https://www.med-sovet.pro/jour/article/view/6573/5958; Wielgosz R., Mroczkowski E. Historia chirurgii wewnatrzusznej. History of endaural surgery. Otolaryngol Pol. 2008;62(3):348-350. https://doi.org/10.1016/S0030-6657(08)70269-5.; Tos M. Manual of middle ear surgery. New York: Thieme Medical Publishers; 1993. 412 p. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1656452/pdf/skullbasesurg00033-0004.pdf.; Heermann H. Johannes Kessel and the history of endaural surgery. Arch Otolaryngol. 1969;90(5):652-658. https://doi.org/10.1001/archo-tol.1969.00770030654025.; Choi N., Noh Y., Park W., Lee J.J., Yook S., Choi J.E. et al. Comparison of Endoscopic Tympanoplasty to Microscopic Tympanoplasty. Clin Exp Otorhinolaryngol. 2017;10(1):44-49. https://doi.org/10.21053/ceo.2016.00080.; Tarabichi M. Endoscopic transcanal middle ear surgery. Indian J Otolaryngol Head Neck Surg. 2010;62(1):6-24. https://doi.org/10.1007/s12070-010-0007-7.; Пальчун В.Т. (ред.). Оториноларингология. Национальное руководство. М.: ГЭОТАР-Медиа; 2014. 656 с. Режим доступа: https://rosmedlib.ru/book/ISBN9785970427354.html.; Свистушкин В.М., Мустафаев Д.М. Современные возможности лечения и профилактики заболеваний наружного уха. РМЖ. 2013;(11):560-564. Режим доступа: https://www.rmj.ru/articles/otorinolaringologiya/Sovremennye_vozmoghnosti_lecheniya_i_profilaktiki_zabolevaniy_narughnogo_uha/.; Sinha A.K., Montgomery J.K., Herer G.R., McPherson D.L. Hearing screening outcomes for persons with intellectual disability: a preliminary report of findings from the 2005 Special Olympics World Winter Games. Int J Audiol. 2008;47(7):399-403. https://doi.org/10.1080/14992020801889535.; Roeser R.J., Ballachanda B.B. Physiology, pathophysiology, and anthropology/ epidemiology of human earcanal secretions. J Am Acad Audiol. 1997;8(6):391-400. Available at: https://pubmed.ncbi.nlm.nih.gov/9433685/.; Keane E.M., Wilson H., McGrane D., Coakley D., Walsh J.B. Use of solvents to disperse ear wax. Br J Clin Pract. 199;49(2):71-72. Available at: https://pub-med.ncbi.nlm.nih.gov/7779647/.; Moore A.M., Voytas J., Kowalski D., Maddens M. Cerumen, hearing, and cognition in the elderly. J Am Med Dir Assoc. 2002;3(3):136-139. https://doi.org/10.1016/S1525-8610(04)70455-7.; Burton M.J., Doree C. Ear drops for the removal of ear wax. Cochrane Database Syst Rev. 2009;(1):CD004326. https://doi.org/10.1002/14651858.CD004326.pub2.; Aaron K., Cooper T.E., Warner L., Burton M.J. Ear drops for the removal of ear wax. Cochrane Database Syst Rev. 2018;7(7):CD012171. https://doi.org/10.1002/14651858.CD012171.pub2.; Hamilton H.W., Hamilton K.R., Lone F.J. Preoperative hair removal. Can J Surg. 1977;20(3):269-275. Available at: https://pubmed.ncbi.nlm.nih.gov/870157/.; Lee D.H., Yoo S., Shin E., Cho Y. Nonshaved Ear Surgery: Effect of Hair on Surgical Site Infection of the Middle Ear/Mastoid Surgery and Patients' Preference for the Hair Removal. J Audiol Otol. 2018;22(3):160-166. https://doi.org/10.7874/jao.2018.00101.; Allegranzi B., Zayed B., Bischoff P., Kubilay N.Z., de Jonge S., de Vries F. et al. New WHO recommendations on intraoperative and postoperative measures for surgical site infection prevention: an evidence-based global perspective. Lancet Infect Dis. 2016;16(12):e288-e303. https://doi.org/10.1016/S1473-3099(16)30398-X.; Гладько В.В., Масюкова С.А., Землякова С.С., Ильина И.В. Новые данные о микробиоме здоровой кожи и его значении в развитии дерматозов (обзор). Дерматология. Приложение к журналу Consilium Medicum. 2017;(4):17-24. Режим доступа: https://www.elibrary.ru/item.asp?id=32301628.; Westerberg B.D., Kozak F.K., Thomas E.E., Blondel-Hill E., Brunstein J.D., Patrick D.M. Is the healthy middle ear a normally sterile site? Otol Neurotol. 2009;30(2):174-177. https://doi.org/10.1097/MAO.0b013e31819225a0.; Frank D.N., Spiegelman G.B., Davis W., Wagner E., Lyons E., Pace N.R. Cultureindependent molecular analysis of microbial constituents of the healthy human outer ear. J Clin Microbiol. 2003;41(1):295-303. https://doi.org/10.1128/JCM.41.1.295-303.2003.; Kong H.H., Segre J.A. Skin microbiome: looking back to move forward. J Invest Dermatol. 2012;132(3):933-939. https://doi.org/10.1038/jid.2011.417.; Updegraff D.M. Methods for determining the distribution of bacteria in the skin. J Am Oil Chem Soc. 1967;44(8):481-483. https://doi.org/10.1007/BF02908540.; Staley J.T., Konopka A. Measurement of in situ activities of nonphotosynthetic microorganisms in aquatic and terrestrial habitats. Annu Rev Microbiol. 1985;39:321-346. https://doi.org/10.1146/annurev.mi.39.100185.001541.; Gao Z., Tseng C.H., Pei Z., Blaser M.J. Molecular analysis of human forearm superficial skin bacterial biota. Proc Natl Acad Sci U S A. 2007;104(8):2927-2932. https://doi.org/10.1073/pnas.0607077104.; Stroman D.W., Roland P.S., Dohar J, Burt W. Microbiology of normal external auditory canal. Laryngoscope. 2001;111(11):2054-2059. https://doi.org/10.1097/00005537-200111000-00035.; Jervis-Bardy J., Leong L.E X, Papanicolas L.E., Ivey K.L., Chawla S., Woods C.M. et al. Examining the Evidence for an Adult Healthy Middle Ear Microbiome. mSphere. 2019;4(5):e00456-19. https://doi.org/10.1128/mSphere.00456-19.; Minami S.B., Mutai H., Suzuki T., Horii A., Oishi N., Wasano K. et al. Microbiomes of the normal middle ear and ears with chronic otitis media. The Laryngoscope. 2017;127(10):371-377. https://doi.org/doi:10.1002/lary.26579.; Trofa D., Gacser A., Nosanchuk J.D. Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev. 2008;21(4):606-625. https://doi.org/10.1128/CMR.00013-08.; Perez R., Freeman S., Sohmer H., Sichel J.Y. Vestibular and cochlear ototoxicity of topical antiseptics assessed by evoked potentials. Laryngoscope. 2000;110(9):1522-1527. https://doi.org/10.1097/00005537-200009000-00021.; Ichibangase T., Yamano T., Miyagi M., Nakagawa T., Morizono T. Ototoxicity of Povidone-Iodine applied to the middle ear cavity of guinea pigs. Int J Pediatr Otorhinolaryngol. 2011;75(9):1078-1081. https://doi.org/10.1016/j.ijporl.2011.05.013.; Singh S., Blakley B. Systematic review of ototoxic pre-surgical antiseptic preparations - what is the evidence? J Otolaryngol Head Neck Surg. 2018;47(1):18. https://doi.org/10.1186/s40463-018-0265-z.; https://www.med-sovet.pro/jour/article/view/6573
-
4Academic Journal
المؤلفون: Безшапочний, Сергій Борисович, Соннік, Наталія Богданівна, Bezshapochny, S. B., Sonnik, N. B.
مصطلحات موضوعية: гострий середній отит, латентний отит, рецидивуючий отит, парацентез, acute otitis media, latent otitis media, recurrent otitis media, paracentesis
Relation: Безшапочний С. Б. Гострий середній отит в дитячому віці / С. Б. Безшапочний, Н. Б. Соннік // Вісник проблем біології і медицини. – 2020. – Вип. 4 (158). – С. 9–12.; 2523–4110; УДК 616.284-002-053.2; http://repository.pdmu.edu.ua/handle/123456789/23040
-
5Academic Journal
المؤلفون: МАЛАЕВА Е.Г.
وصف الملف: text/html
-
6Academic Journal
المؤلفون: Малаева, Е. Г.
مصطلحات موضوعية: асцит, цирроз печени, диуретики, вазоконстрикторы, лечебный объемный парацентез, трансплантация печени
Relation: Малаева, Е. Г. Тактика ведения асцита у пациентов с циррозом печени / Е. Г. Малаева // Проблемы здоровья и экологии. – 2012. - № 3 (33). – С. 28-35.; http://elib.gsmu.by/handle/GomSMU/449
-
7
المصدر: Проблемы здоровья и экологии.
وصف الملف: text/html
-
8
المصدر: Медицинский альманах.
وصف الملف: text/html
